Daniel P. McKee

476 total citations
10 papers, 368 citations indexed

About

Daniel P. McKee is a scholar working on Hepatology, Epidemiology and Gastroenterology. According to data from OpenAlex, Daniel P. McKee has authored 10 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Epidemiology and 3 papers in Gastroenterology. Recurrent topics in Daniel P. McKee's work include Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Gastrointestinal motility and disorders (3 papers). Daniel P. McKee is often cited by papers focused on Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Gastrointestinal motility and disorders (3 papers). Daniel P. McKee collaborates with scholars based in United States. Daniel P. McKee's co-authors include Eamonn M.M. Quigley, Joseph Galati, Kristen L. Barry, James R. Greenley, Michael F. Fleming, Simon Maher, Alain H. Litwin, Bryce D. Smith, Elisa Koppelman and William N. Southern and has published in prestigious journals such as Gastroenterology, Schizophrenia Bulletin and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Daniel P. McKee

9 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel P. McKee United States 7 206 124 79 79 62 10 368
Teodora Surdea‐Blaga Romania 11 314 1.5× 42 0.3× 194 2.5× 19 0.2× 27 0.4× 39 462
Billy D. Nix United States 13 112 0.5× 164 1.3× 104 1.3× 16 0.2× 91 1.5× 23 524
William F. Norton United States 7 355 1.7× 28 0.2× 142 1.8× 8 0.1× 40 0.6× 10 452
David J. Cangemi United States 12 297 1.4× 34 0.3× 260 3.3× 11 0.1× 20 0.3× 43 477
Ann Scheimann United States 11 39 0.2× 133 1.1× 74 0.9× 42 0.5× 55 0.9× 19 415
Cynthia M. Tsai United States 9 177 0.9× 17 0.1× 84 1.1× 9 0.1× 56 0.9× 24 382
John T. Stutts United States 8 154 0.7× 73 0.6× 89 1.1× 15 0.2× 49 0.8× 14 337
Tso‐Tsai Liu Taiwan 17 526 2.6× 138 1.1× 475 6.0× 79 1.0× 21 0.3× 89 824
James E. Mayle United States 6 363 1.8× 29 0.2× 260 3.3× 4 0.1× 55 0.9× 10 606
Agustín Balboa Spain 13 527 2.6× 54 0.4× 330 4.2× 3 0.0× 39 0.6× 31 619

Countries citing papers authored by Daniel P. McKee

Since Specialization
Citations

This map shows the geographic impact of Daniel P. McKee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. McKee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. McKee more than expected).

Fields of papers citing papers by Daniel P. McKee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. McKee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. McKee. The network helps show where Daniel P. McKee may publish in the future.

Co-authorship network of co-authors of Daniel P. McKee

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. McKee. A scholar is included among the top collaborators of Daniel P. McKee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. McKee. Daniel P. McKee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
McKee, Daniel P., et al.. (2023). A Comprehensive Review of the Genetic and Epigenetic Contributions to the Development of Fibromyalgia. Biomedicines. 11(4). 1119–1119. 22 indexed citations
2.
Ho, Samuel B., Eric Dieperink, Shanglei Liu, et al.. (2011). U.S. Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients. Digestive Diseases and Sciences. 56(3). 880–888. 5 indexed citations
3.
Southern, William N., Mari‐Lynn Drainoni, Bryce D. Smith, et al.. (2010). Hepatitis C testing practices and prevalence in a high‐risk urban ambulatory care setting. Journal of Viral Hepatitis. 18(7). 474–481. 60 indexed citations
5.
Saeian, Kia, Jasmohan S. Bajaj, José Franco, et al.. (2004). High‐dose vitamin E supplementation does not diminish ribavirin‐associated haemolysis in hepatitis C treatment with combination standard α‐interferon and ribavirin. Alimentary Pharmacology & Therapeutics. 20(10). 1189–1193. 16 indexed citations
6.
Gross, John, et al.. (1998). High dose induction therapy with alpha interferon is effective in patients with high hepatitis C viral load. Gastroenterology. 114. A1247–A1247. 4 indexed citations
7.
Barry, Kristen L., et al.. (1995). Assessment of Alcohol and Other Drug Disorders in the Seriously Mentally Ill. Schizophrenia Bulletin. 21(2). 313–321. 45 indexed citations
8.
Galati, Joseph, Daniel P. McKee, & Eamonn M.M. Quigley. (1995). Response to intraluminal gas in irritable bowel syndrome. Digestive Diseases and Sciences. 40(6). 1381–1387. 49 indexed citations
9.
McKee, Daniel P. & Eamonn M.M. Quigley. (1993). Intestinal motility in irritable bowel syndrome: Is IBS a motility disorder?. Digestive Diseases and Sciences. 38(10). 1773–1782. 76 indexed citations
10.
McKee, Daniel P. & Eamonn M.M. Quigley. (1993). Intestinal motility in irritable bowel syndrome: Is IBS a motility disorder?. Digestive Diseases and Sciences. 38(10). 1761–1772. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026